Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Molina Healthcare, Inc. (MOH) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / July 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE:MOH). Investors who purchased Molina securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MOH.

Investigation Details

On July 7, 2025, Molina provided preliminary financial results for the second quarter 2025, including adjusted earnings for the quarter of approximately $5.50 per share. The Company also lowered its full year 2025 adjusted earning guidance by over 10% to $21.50 to $22.50 per share. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume. Then, on July 23, 2025, Molina released its second quarter 2025 financial results, including adjusted earnings per diluted share of $5.48, missing consensus estimates and prior guidance due in part to "medical cost pressure due to continued utilization of behavioral health, pharmacy, and inpatient and outpatient services." The Company also further reduced its full year 2025 guidance, stating that the updated guidance "reflects new information gained in the quarterly closing process and implications for medical cost trend assumptions for the second half of the year." Following this news, Molina’s stock price dropped.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Molina securities, you can assist this investigation by visiting the firm’s site: bgandg.com/MOH. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_467628205/2457/2025-07-28T13:13:04

Scroll to Top